Genichiro Ishii

14.7k total citations
271 papers, 9.6k citations indexed

About

Genichiro Ishii is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Genichiro Ishii has authored 271 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Oncology, 142 papers in Pulmonary and Respiratory Medicine and 46 papers in Molecular Biology. Recurrent topics in Genichiro Ishii's work include Lung Cancer Treatments and Mutations (92 papers), Lung Cancer Diagnosis and Treatment (83 papers) and Cancer Cells and Metastasis (60 papers). Genichiro Ishii is often cited by papers focused on Lung Cancer Treatments and Mutations (92 papers), Lung Cancer Diagnosis and Treatment (83 papers) and Cancer Cells and Metastasis (60 papers). Genichiro Ishii collaborates with scholars based in Japan, United States and United Kingdom. Genichiro Ishii's co-authors include Atsushi Ochiai, Kanji Nagai, Junji Yoshida, Keiju Aokage, Kōichi Goto, Tomoyuki Hishida, Shinya Neri, Mitsuyo Nishimura, Masahiro Tsuboi and Motohiro Kojima and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Genichiro Ishii

255 papers receiving 9.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Genichiro Ishii Japan 55 5.5k 3.4k 2.9k 1.8k 1.4k 271 9.6k
Peter Birner Austria 49 4.0k 0.7× 2.1k 0.6× 3.3k 1.1× 2.2k 1.3× 1.2k 0.9× 169 9.0k
Doo Hyun Chung South Korea 54 4.5k 0.8× 5.0k 1.4× 2.5k 0.8× 1.4k 0.8× 2.1k 1.6× 235 9.4k
Patrick Pauwels Belgium 60 4.2k 0.8× 3.2k 0.9× 4.3k 1.5× 2.9k 1.7× 1.2k 0.9× 305 10.6k
Jean‐Pierre Delord France 43 5.5k 1.0× 2.0k 0.6× 2.2k 0.8× 1.1k 0.6× 1.7k 1.3× 260 8.4k
Massimo Roncalli Italy 59 4.7k 0.9× 3.3k 1.0× 3.2k 1.1× 1.8k 1.0× 1.6k 1.2× 228 11.5k
Zev A. Wainberg United States 51 6.2k 1.1× 3.2k 0.9× 2.8k 1.0× 1.4k 0.8× 1.3k 1.0× 343 9.8k
Rajmohan Murali United States 51 4.3k 0.8× 2.2k 0.6× 3.1k 1.1× 1.6k 0.9× 1.2k 0.9× 179 8.5k
Jeffrey A. Drebin United States 47 6.6k 1.2× 2.3k 0.7× 3.2k 1.1× 1.6k 0.9× 1.8k 1.3× 211 11.1k
Zoran Gatalica United States 55 4.8k 0.9× 3.3k 1.0× 3.3k 1.1× 2.3k 1.3× 1.3k 0.9× 328 10.9k
Jahn M. Nesland Norway 53 3.7k 0.7× 2.2k 0.6× 3.5k 1.2× 2.3k 1.3× 852 0.6× 194 9.1k

Countries citing papers authored by Genichiro Ishii

Since Specialization
Citations

This map shows the geographic impact of Genichiro Ishii's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Genichiro Ishii with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Genichiro Ishii more than expected).

Fields of papers citing papers by Genichiro Ishii

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Genichiro Ishii. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Genichiro Ishii. The network helps show where Genichiro Ishii may publish in the future.

Co-authorship network of co-authors of Genichiro Ishii

This figure shows the co-authorship network connecting the top 25 collaborators of Genichiro Ishii. A scholar is included among the top collaborators of Genichiro Ishii based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Genichiro Ishii. Genichiro Ishii is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nomura, Kotaro, Keiju Aokage, Tokiko Nakai, et al.. (2024). EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system. International Journal of Clinical Oncology. 29(3). 248–257. 2 indexed citations
2.
Ishii, Genichiro. (2024). New insights into cancer pathology learned from the dynamics of cancer‐associated fibroblasts. Pathology International. 74(9). 493–507. 1 indexed citations
3.
Nagasaki, Yusuke, Tetsuro Taki, Kotaro Nomura, et al.. (2024). Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancer. JNCI Journal of the National Cancer Institute. 116(7). 1158–1168.
4.
Aokage, Keiju, Shohei Koyama, Shogo Kumagai, et al.. (2024). Efficacy, Safety, and Influence on the Tumor Microenvironment of Neoadjuvant Pembrolizumab plus Ramucirumab for PD-L1–Positive NSCLC: A Phase II Trial (EAST ENERGY). Clinical Cancer Research. 30(24). 5584–5592. 4 indexed citations
5.
Kojima, Motohiro, Toshiyuki Suzuki, Genichiro Ishii, et al.. (2023). Relationships between physical and immunological tumor microenvironment in pancreatic ductal adenocarcinoma. Cancer Science. 114(9). 3783–3792. 3 indexed citations
6.
Tabata, Sho, Shigeki Umemura, Hibiki Udagawa, et al.. (2023). Metabolic Hallmarks for Purine Nucleotide Biosynthesis in Small Cell Lung Carcinoma. Molecular Cancer Research. 22(1). 82–93. 6 indexed citations
7.
Itahashi, Kota, Takuma Irie, Junichiro Yuda, et al.. (2022). BATF epigenetically and transcriptionally controls the activation program of regulatory T cells in human tumors. Science Immunology. 7(76). eabk0957–eabk0957. 60 indexed citations
8.
Adachi, Masahiro, Naoki Aoyama, Motohiro Kojima, et al.. (2022). The area of residual tumor predicts esophageal squamous cell carcinoma prognosis following neoadjuvant chemotherapy. Journal of Cancer Research and Clinical Oncology. 149(8). 4663–4673. 2 indexed citations
9.
Hoshino, Hironobu, Keiju Aokage, Tomohiro Miyoshi, et al.. (2021). Correlation between the number of viable tumor cells and immune cells in the tumor microenvironment in non‐small cell lung cancer after induction therapy. Pathology International. 71(8). 512–520. 2 indexed citations
10.
Miyoshi, Tomohiro, Keiju Aokage, Jun Suzuki, et al.. (2021). Prognostic impact of the tumor immune microenvironment in pulmonary pleomorphic carcinoma. Lung Cancer. 153. 56–65. 10 indexed citations
11.
Maeda, Masahiro, Hideyuki Takeshima, Naoko Iida, et al.. (2019). Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3. Gut. 69(2). 243–251. 70 indexed citations
12.
Sakai, Takashi, Tomohiro Miyoshi, Shigeki Umemura, et al.. (2019). Large pulmonary sclerosing pneumocytoma with massive necrosis and vascular invasion: a case report. Oxford Medical Case Reports. 2019(7). 8 indexed citations
13.
Makinoshima, Hideki, Shigeki Umemura, Ayako Suzuki, et al.. (2018). Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma. Cancer Research. 78(9). 2179–2190. 33 indexed citations
14.
Sakai, Takashi, Keiju Aokage, Shinya Neri, et al.. (2018). Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma. Lung Cancer. 126. 64–71. 46 indexed citations
15.
Ishii, Genichiro. (2018). 肺癌の病理組織分類―Update―. Haigan. 58(Supplement). 898–902.
16.
Miyoshi, Tomohiro, Shigeki Umemura, Yuki Matsumura, et al.. (2016). Genomic Profiling of Large-Cell Neuroendocrine Carcinoma of the Lung. Clinical Cancer Research. 23(3). 757–765. 139 indexed citations
17.
Yoshida, Tatsuya, Genichiro Ishii, Kōichi Goto, et al.. (2014). Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation. Clinical Cancer Research. 21(3). 642–651. 102 indexed citations
18.
Hoshino, Ayuko, Genichiro Ishii, Tetsufumi Ito, et al.. (2011). Podoplanin-Positive Fibroblasts Enhance Lung Adenocarcinoma Tumor Formation: Podoplanin in Fibroblast Functions for Tumor Progression. Cancer Research. 71(14). 4769–4779. 145 indexed citations
19.
Kawase, Akikazu, Genichiro Ishii, Kanji Nagai, et al.. (2008). Podoplanin expression by cancer associated fibroblasts predicts poor prognosis of lung adenocarcinoma. International Journal of Cancer. 123(5). 1053–1059. 184 indexed citations
20.
Ishii, Genichiro, Atsushi Ochiai, Kiyotaka Yoh, et al.. (2006). Eg5 expression is closely correlated with response of advanced non-small cell lung cancer to antimitotic agents combined with platinum chemotherapy. Cancer Research. 66. 1065–1065. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter Birner Breakdown of academic impact, for papers by Doo Hyun Chung Breakdown of academic impact, for papers by Patrick Pauwels Breakdown of academic impact, for papers by Jean‐Pierre Delord Breakdown of academic impact, for papers by Massimo Roncalli Breakdown of academic impact, for papers by Zev A. Wainberg Breakdown of academic impact, for papers by Rajmohan Murali Breakdown of academic impact, for papers by Jeffrey A. Drebin Breakdown of academic impact, for papers by Zoran Gatalica Breakdown of academic impact, for papers by Jahn M. Nesland
Rankless by CCL
2026